Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy | MicrobiomeTrials← Back to trialsNCT07215273
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-13Est. Completion: 2026-12
Enrollment target: 60 participants Locations- U. of Alabama at Birmingham, Birmingham, Alabama, United States
- UC Davis Medical Center, Sacramento, California, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- John Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- U. of Michigan, Ann Arbor, Michigan, United States
- Washington U., St Louis, Missouri, United States
- U. of Texas, MD Anderson, Houston, Texas, United States
- U. of Texas Health Sciences Center at San Antonio, San Antonio, Texas, United States
- U. of Washington, Seattle, Washington, United States
- AZ Sint-Jan Brugge, Bruges, Belgium
- Universite Libre de Bruxelles (ULB) - Institut Jules Bordet, Brussels, Belgium
- UZ Gent, Ghent, Belgium
- UZ Leuven, Leuven, Belgium
- Centre Hospitalier Universitaire (CHU) de Liege, Liège, Belgium
- Vancouver General Hospital, Vancouver, British Columbia, Canada
Other microbiome trials you might be interested in
AspergillosMucormyeDimorphicOther MoldsNon-AspergillosNon-Mucormycosis
Background:
Fungal infections can cause serious disease in the lungs and other parts of the body. About 3.8 million peo…
Bethesda, United StatesEst. completion Jun 30, 2029
Liver Transplant InfectionFungal Infection
This is an interventional study to evaluate the efficacy of rezafungin, a new echinocandin, for the prevention of invasi…
Juravinski Hospital, Hamilton, Ontario, CanadaUniversity Health Network (UHN) - Princess Margaret Cancer Centre, Toronto, Ontario, CanadaCentre Hospitalier d'Argenteuil, Argenteuil, FranceAP-HP Hopital Henri Modor, Créteil, FranceAP-HP Hopital Saint-Louis, Paris, FranceIstituto Europeo di Oncologia, Milan, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS- Universita Cattolica del Sacro Cuore, Roma, ItalyHospital del Mar, Barcelona, SpainHospital Universitario Vall d'Hebron, Barcelona, SpainHospital Clinic Barcelona, Barcelona, SpainHospital Universitario 12 de Octubre, Madrid, SpainHospital Universitario Puerta de Hierro, Majadahonda, SpainHospital Clinico Universitario de Salamanca, Salamanca, SpainPittsburgh, United States
Completed Dec 2028